Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
J Korean Assoc Oral Maxillofac Surg. 2010 Jun;36(3):206-210. Korean. Original Article. https://doi.org/10.5125/jkaoms.2010.36.3.206
You KH , Yoon KH , Bae JH , Park JA , Park GC , Shin JM , Baik JS , Cheong JK .
Department of Oral and Maxillofacial Surgery, Inje University Sanggye Paik Hospital, Seoul, Korea. dentpd@paik.ac.kr
Department of Oral and Maxillofacial Surgery, Inje University Ilsan Paik Hospital, Goyang, Korea.
Abstract

Bisphosphonates are widely used to treat osteoporosis, hypercalcemia of malignant tumor. Despite their clinical benefit, bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a newly documented complication to patients receiving these drugs and first recognized by Marx in 2003. Thus, consideration of prevention and needs regarding unequivocal treatment regimen have emerged. Recently, several authors emphasized reports on appropriate clinical availability of surgical approach. It serves to concern about guideline for surgical and conservative treatment modalities. So, it is the purpose of this paper to review the current literatures about treatment regimens of BRONJ.

Copyright © 2019. Korean Association of Medical Journal Editors.